Pfizer announces creation of new partnering model
Pfizer announced the creation of the Innovative Target Exploration Network, a new, early-stage partnering model that enables collaborative relationships with select academic institutions and principal investigators around the world, to identify research projects that have the potential to deliver novel therapeutic targets and mechanisms of action to underpin future drug discovery in core areas of interest to Pfizer. Complementing Pfizer's long-standing commitment to academic collaboration, the ITEN model will allow researchers from Pfizer and partner institutions to share ideas for pairing academia's cutting-edge research with industry's translational capabilities and wide network of resources and relationships. The University of Cambridge and the University of Oxford are the first to participate in the ITEN model in the United Kingdom, and the University of Texas Southwestern is the first to participate in the United States. Pfizer is seeking to selectively include other institutions to be part of the ITEN model.